Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands

Medical treatment for acromegaly commonly involves receiving intramuscular or deep subcutaneous injections of somatostatin receptor ligands (SRLs) in most patients. In addition to side effects of treatment, acromegaly patients often still experience disease symptoms even when therapy is successful i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleseriu, Maria, Molitch, Mark, Dreval, Alexander, Biermasz, Nienke R., Gordon, Murray B., Crosby, Ross D., Ludlam, William H., Haviv, Asi, Gilgun-Sherki, Yossi, Mathias, Susan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006928/
https://www.ncbi.nlm.nih.gov/pubmed/33790860
http://dx.doi.org/10.3389/fendo.2021.627711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006928/
https://www.ncbi.nlm.nih.gov/pubmed/33790860
http://dx.doi.org/10.3389/fendo.2021.627711

Ejemplares similares